Coarctation of the Aorta with VSD — Physiology
The “dual stress on the LV” model (pressure + volume)
When coarctation of the aorta (CoA) coexists with a ventricular septal defect (VSD), the circulation behaves like two classic lesions superimposed:
- CoA = pressure overload (fixed obstruction in the systemic outflow pathway → ↑ LV afterload)
- VSD = volume overload (as PVR falls, L→R shunt → ↑ Qp → ↑ pulmonary venous return → ↑ LA/LV preload)
Take-home concept: the LV is forced to generate higher pressure while handling higher volume at the same time — the hemodynamic signature of “dual stress on the LV.”
1) Core hemodynamic logic (what makes CoA + VSD uniquely demanding)
A) CoA drives afterload rise proximal to the isthmus
- LV ejection meets a high-resistance segment at the arch/isthmus.
- Consequences (especially in neonates):
- ↑ LV systolic pressure requirement → ↑ wall stress
- If compensation fails: ↑ LVEDP/LA pressure → pulmonary congestion
- Distal hypoperfusion (renal/gut/lower extremity), particularly when ductal flow is critical
B) VSD drives pulmonary overcirculation → LA/LV volume load
- In a large/nonrestrictive VSD, shunt magnitude is governed by the PVR vs SVR balance.
- As PVR falls postnatally, L→R shunt increases:
- ↑ Qp → ↑ pulmonary venous return → LA/LV dilation
- ↑ LA pressure → pulmonary edema/CHF physiology
C) Combined effect = LV “pressure + volume” overload
- CoA raises pressure work (afterload); VSD raises volume work (preload).
- This combination accelerates:
- Pulmonary edema/CHF
- LV dysfunction (especially during ductal constriction)
- Systemic hypoperfusion to the lower body (CoA-dependent)
2) The two-circuit competition (Qp/Qs is dynamic, not static)
A practical way to teach this lesion is as a moving equilibrium:
- Qp rises when PVR is low and the VSD is large → CHF risk increases
- Qs is limited by arch obstruction; if severe, the descending aorta becomes ductal-dependent
- Therefore, physiology can swing over hours–days in neonates, and can shift with:
- ventilation/oxygenation (via PVR)
- acidosis (via PVR/SVR and myocardial function)
- vasoactives (via SVR and LV workload)
- ductal patency
3) The PDA as a temporary “systemic bypass”
In critical CoA physiology, the PDA can provide essential descending aortic flow (often R→L across the ductus), supporting:
- renal perfusion / urine output
- gut and lower-body perfusion
- metabolic stability (lactate)
This is the physiologic rationale for PGE1 during stabilization: it can “buy time” while definitive repair strategy is chosen.
4) Why neonates can “crash” (typical time-course)
A common clinical sequence:
- Early after birth (PVR still relatively high):
- VSD shunt may be modest
- distal perfusion may be supported by an open PDA
- Ductal constriction:
- sudden drop in lower-body perfusion → oliguria, acidosis, shock physiology
- abrupt afterload jump on the LV
- PVR fall over days:
- VSD becomes a low-resistance outlet → ↑ Qp → pulmonary edema/CHF
- paradox: pulmonary overcirculation + systemic hypoperfusion can coexist
5) Clinical phenotypes (bedside patterns)
- CHF-dominant phenotype: tachypnea, feeding intolerance, hepatomegaly (large L→R shunt as PVR falls)
- Perfusion-dominant phenotype (critical CoA): weak femoral pulses, cool legs, oliguria, lactic acidosis (ductal-dependent systemic flow)
- Mixed phenotype: pulmonary edema + low output/shock features (classic “dual stress” presentation)
6) Stabilization principles (physiology-first ICU priorities)
A practical sequence:
- Maintain systemic delivery to the lower body
- PGE1 if ductal-dependent physiology is suspected/confirmed
- Protect the LV and lungs
- avoid unnecessarily increasing LV workload
- treat pulmonary congestion (ventilation/diuresis as needed)
- Plan definitive anatomic correction
- physiology will not “self-resolve” because obstruction + shunt persist
7) Definitive repair strategy: one-stage vs staged (what the evidence supports)
The modern literature supports a case-adapted strategy, because no single approach is universally superior.
A) What comparative studies and meta-analysis show
- Across eras, one-stage (arch + VSD in one operation) and staged strategies show similar overall mortality in neonatal CoA + VSD populations, with outcomes largely driven by anatomy and patient condition rather than strategy alone. [4,6,7]
- Reintervention (especially recoarctation/arch reintervention) remains a relevant endpoint across approaches. In a large infant cohort, ~11.5% required arch reintervention during follow-up, and proportions were similar across surgical strategy groups. [6]
B) Patient-specific factors that should drive strategy selection
- Arch anatomy: degree of arch hypoplasia / complexity of reconstruction
- VSD physiology: size, restrictiveness, shunt burden (Qp/Qs), likelihood of spontaneous change
- Physiologic reserve: ventricular function, end-organ status, prematurity/low weight
- Ductal physiology / PGE1 dependence: may correlate with higher recoarctation risk and can complicate preoperative definition of resection boundaries [6]
C) A practical “strategy bias” (how many centers think)
- One-stage repair tends to be favored when:
- significant arch hypoplasia requiring comprehensive reconstruction
- large/nonrestrictive VSD with clear CHF physiology
- goal is complete repair in infancy and avoidance of a second operation [4,5]
- Staged repair remains valuable when:
- unstable physiology or fragile patient factors make complexity hazardous
- initial arch repair ± PA band can stabilize Qp/Qs before later VSD closure [2,3,7]
Slide-friendly teaching sentences
- CoA + VSD = “dual stress on the LV”: CoA creates pressure overload; VSD adds volume overload once PVR falls.
- Physiology is dynamic: Qp/Qs shifts with PVR–SVR balance, ventilation, vasoactives, and ductal patency.
- PDA can temporarily rescue systemic flow: in critical CoA, the ductus functions as a descending-aorta lifeline until repair.
References (PubMed-indexed)
[1] Gaynor JW, Wernovsky G, Rychik J, Rome JJ, DeCampli WM, Spray TL. Outcome following single-stage repair of coarctation with ventricular septal defect. Eur J Cardiothorac Surg. 2000;18(1):62-67. doi:10.1016/S1010-7940(00)00440-1.
[2] Isomatsu Y, Imai Y, Shin’oka T, Aoki M, Kurosawa H. Coarctation of the aorta and ventricular septal defect: Should we perform a single-stage repair? J Thorac Cardiovasc Surg. 2001;122(3):524-528.
[3] Walters HL 3rd, Ionan CE, Thomas RL, Delius RE. Single-stage versus 2-stage repair of coarctation of the aorta with ventricular septal defect. J Thorac Cardiovasc Surg. 2008;135(4):754-761. doi:10.1016/j.jtcvs.2007.12.008.
[4] Kanter KR. Management of infants with coarctation and ventricular septal defect. Semin Thorac Cardiovasc Surg. 2007;19(3):264-268. doi:10.1053/j.semtcvs.2007.07.003.
[5] Plunkett MD, Bond SJ, Huddleston CB. Management of an associated ventricular septal defect at the time of coarctation repair. Ann Thorac Surg. 2014;98(4):1412-1418. doi:10.1016/j.athoracsur.2014.05.076.
[6] Lehnert A, Villemain O, Gaudin R, Méot M, Raisky O, Bonnet D. Risk factors of mortality and recoarctation after coarctation repair in infancy. Interact Cardiovasc Thorac Surg. 2019;29(3):469-475. doi:10.1093/icvts/ivz117.
[7] Kasdi R, Bounader K, Lemdani M. Neonatal management of aortic coarctation with ventricular septal defect: a systematic review and meta-analysis. J Cardiovasc Surg (Torino). 2020;61(4):478-488. doi:10.23736/S0021-9509.20.11075-9.